StonvexLoading…
StonvexCore line items from DAR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-04 | Annual 2026 2026-01-03 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $1.55B | $6.14B | $4.43B | $2.86B |
Operating Income | $226.77M | $273.44M | $175.99M | $104.27M |
Net Income | $134.31M | $62.80M | $5.86M | $-13.50M |
EPS (Diluted) | $0.83 | $0.39 | $0.04 | $-0.09 |
Total Assets | $10.64B | $10.30B | $10.45B | $10.27B |
Total Liabilities | $5.70B | $5.49B | $5.68B | $5.58B |
Cash & Equivalents | $116.02M | $88.67M | $91.49M | $94.58M |
Free Cash Flow OCF − CapEx | Not available | $679.24M | Not available | Not available |
Shares Outstanding | 161.03M | 160.16M | 160.07M | 158.44M |